日期 | 股东名称 | 披露原因 | 买入/卖出涉及 的股份数目 |
每股平均价 | 持有权益的 股份数目 |
占已发行 股本(%) |
09/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,300,000(L) | HKD3.848(L) | 842,548,000(L) | 28.38 |
05/09/2024 | 曲继广 | 1113(L) | +2,200,000(L) | HKD3.908(L) | 1,126,656,000(L) | 37.94 |
05/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +2,200,000(L) | HKD3.908(L) | 841,248,000(L) | 28.33 |
04/09/2024 | 曲继广 | 1113(L) | +1,000,000(L) | HKD3.906(L) | 1,124,456,000(L) | 37.87 |
04/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD3.906(L) | 839,048,000(L) | 28.26 |
03/09/2024 | 曲继广 | 1113(L) | +1,000,000(L) | HKD3.920(L) | 1,123,456,000(L) | 37.84 |
03/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD3.920(L) | 838,048,000(L) | 28.23 |
02/09/2024 | China Pharmaceutical Company Limited | 1710(L) | +2,000,000(L) | HKD3.873(L) | 837,048,000(L) | 28.19 |
02/09/2024 | 曲继广 | 1113(L) | +2,000,000(L) | HKD3.873(L) | 1,122,056,000(L) | 37.79 |
02/09/2024 | 曲继广 | 1101(L) | +400,000(L) | HKD3.811(L) | 1,122,456,000(L) | 37.80 |
30/08/2024 | 曲继广 | 1113(L) | +2,350,000(L) | HKD3.890(L) | 1,120,056,000(L) | 37.72 |
30/08/2024 | China Pharmaceutical Company Limited | 1710(L) | +2,350,000(L) | HKD3.890(L) | 835,048,000(L) | 28.12 |
21/08/2024 | 四川科伦药业股份有限公司 | 1101(L) | +5,930,000(L) | HKD3.536(L) | 628,776,000(L) | 21.18 |
18/04/2024 | China Pharmaceutical Company Limited | 1710(L) | +1,000,000(L) | HKD4.675(L) | 832,698,000(L) | 28.05 |
18/04/2024 | 曲继广 | 1113(L) | +1,000,000(L) | HKD4.675(L) | 1,117,706,000(L) | 37.65 |
17/04/2024 | China Pharmaceutical Company Limited | 1101(L) | +800,000(L) | HKD4.763(L) | 831,698,000(L) | 28.01 |
17/04/2024 | 曲继广 | 1113(L) | +800,000(L) | HKD4.763(L) | 1,116,706,000(L) | 37.61 |
05/04/2024 | 曲继广 | 1113(L) | +524,000(L) | HKD4.815(L) | 1,115,906,000(L) | 37.58 |
05/04/2024 | China Pharmaceutical Company Limited | 1710(L) | +524,000(L) | HKD4.815(L) | 830,898,000(L) | 27.98 |
03/04/2024 | 曲继广 | 1101(L) | +1,500,000(L) | HKD5.009(L) | 1,115,382,000(L) | 37.57 |
02/04/2024 | 曲继广 | 1113(L) | +2,000,000(L) | HKD5.122(L) | 1,113,882,000(L) | 37.52 |
02/04/2024 | China Pharmaceutical Company Limited | 1710(L) | +2,000,000(L) | HKD5.122(L) | 830,374,000(L) | 27.97 |
28/03/2024 | 曲继广 | 1101(L) | +500,000(L) | HKD4.904(L) | 1,111,882,000(L) | 37.45 |
08/03/2024 | UBS Group AG | 1205(L) | -251,000(L) | 296,869,657(L) | 9.99 | |
07/03/2024 | UBS Group AG | 1313(L) | 554,000(L) | 297,084,657(L) | 10.01 | |
06/03/2024 | UBS Group AG | 1104(L) | +255,000(L) | 297,092,657(L) | 10.01 | |
04/03/2024 | UBS Group AG | 1205(L) | -51,335(L) | 296,855,657(L) | 9.99 | |
03/01/2024 | UBS Group AG | 1306(L) | 388,000(L) | 304,670,509(L) | 10.26 | |
1 2 |
备注: | (L) - 长仓:包括 (1) 持有股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任购买相关股份。 |
(S) - 短仓:包括 (1) 借入股份;(2) 透过持有丶沽出或发行金融合约,有权或有责任沽出相关股份。 | |
(P) - 可供借出的股份 | |
即时报价更新时间为 08/01/2025 18:00 | |
港股实时基本市场行情由香港交易所提供; 香港交易所指定免费发放实时基本市场行情的网站。 | |